Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin

Biochemical and Biophysical Research Communications

Volumn 327, Issue 1, 2005, Pages 225-233

  Chang, In Youb ^a,b   Kim, Mi Hwa ^a   Kim, Hong Beum ^a   Lee, Do Yung ^a   Kim, Soo Hyun ^a   Kim, Han Yong ^a   You, Ho Jin ^a  

^a Chosun University   (South Korea)

^b Seonam University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; OXALIPLATIN; RNA;

ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SYNTHESIS;

CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DNA REPAIR; DNA-BINDING PROTEINS; DOWN-REGULATION; ENDONUCLEASES; HUMANS; NEOPLASMS; PLATINUM; RNA INTERFERENCE; RNA, SMALL INTERFERING;

MINK CELL FOCUS-FORMING VIRUS;

EID: 11144241323     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.12.008     Document Type: Article

References (38)

1. D.E. Szymkowski, K. Yarema, J.M. Essigmann, S.J. Lippard, and R.D. Wood An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts Proc. Natl. Acad. Sci. USA 89 1992 10772 10776
2. Z. Suo, S.J. Lippard, and K.A. Johnson Single d(GpG)/cis- diammineplatinum(II) adduct-induced inhibition of DNA polymerization Biochemistry 38 1999 715 726
3. D.B. Zamble, and S.J. Lippard Cisplatin and DNA repair in cancer chemotherapy Trends Biochem. Sci. 20 1995 435 439
4. E. Reed Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy Cancer Treat. Rev. 24 1998 331 344
5. J.T. Reardon, A. Vaisman, S.G. Chaney, and A. Sancar Efficient nucleotide excision repair of cisplatin, oxaliplatin, and bis-aceto-ammine-dichloro- cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts Cancer Res. 59 1999 3968 3971
6. J. de Boer, and J.H. Hoeijmakers Nucleotide excision repair and human syndromes Carcinogenesis 21 2000 453 460
7. D.P. Batty, and R.D. Wood Damage recognition in nucleotide excision repair of DNA Gene 241 2000 193 204
8. C.H. Park, D. Mu, J.T. Reardon, and A. Sancar The general transcription-repair factor TFIIH is recruited to the excision repair complex by the XPA protein independent of the TFIIE transcription factor J. Biol. Chem. 270 1995 4896 4902
9. A. Sancar Excision repair in mammalian cells J. Biol. Chem. 270 1995 15915 15918
10. M. van Duin, J. de Wit, H. Odijk, A. Westerveld, A. Yasui, H.M. Koken, J.H. Hoeijmakers, and D. Bootsma Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10 Cell 44 1986 913 923
11. J.J. Yu, K.B. Lee, C. Mu, Q. Li, T.V. Abernathy, F. Bostick-Bruton, and E. Reed Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCCI gene Int. J. Oncol. 16 2000 555 560
12. K.B. Lee, R.J. Parker, V. Bohr, T. Cornelison, and E. Reed Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups I and 3 Carcinogenesis 14 1993 2177 2180
13. R.V. Rosell, R.V. Lord, M. Taron, and N. Reguart DNA repair and cisplatin resistance in non-small-cell lung cancer Lung Cancer 38 2002 217 227
14. Q. Li, J.J. Yu, C. Mu, M.K. Yunmbam, D. Slavsky, C.L. Cross, F. Bostick-Bruton, and E. Reed Association between the level of ERCC- I expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells Anticancer Res. 20 2000 645 652
15. A. Westerveld, J.H. Hoeijmakers, M. van Duin, J. de Wit, H. Odijk, A. Pastink, R.D. Wood, and D. Bootsma Molecular cloning of a human DNA repair gene Nature (Lond.) 310 1984 425 429
16. D.W. Melton, A.M. Ketchen, F. Nunez, S. Bonatti-Abbondandolo, A. Abbondandolo, S. Squires, and R.T. Johnson Cells from ERCC I-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination J. Cell Sci. 111 1998 395 404
17. M. Dabholkar, J. Vionnet, F. Bostick Bruton, J.J. Yu, and E. Reed Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy J. Clin. Invest. 94 1994 703 708
18. R.A. Britten, D. Liu, A. Tessier, M.J. Hutchison, and D. Murray ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells Int. J. Cancer 89 2000 453 457
19. A. Fire RNA-triggered gene silencing Trends Genet. 15 1999 358 363
20. D.M. Dykxhoorn, C.D. Novina, and P.A. Sharp Killing the messenger: short RNAs that silence gene expression Nat. Rev. Mol. Cell Biol. 4 2003 457 467
21. P.D. Zamore RNA interference: listening to the sound of silence Nat. Struct. Biol. 8 2001 746 750
22. T. Tuschl RNA interference and small interfering RNAs Chembiochem 2 2001 239 245
23. P.J. Paddison, A.A. Caudy, E. Bernstein, G.J. Hannon, and D.S. Conklin Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells Genes Dev. 16 2002 948 958
24. J.Y. Yu, S.L. DeRuiter, and D.L. Turner RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells Proc. Natl. Acad. Sci. USA 99 2002 6047 6052
25. N.J. Caplen A new approach to the inhibition of gene expression Trends Biotechnol. 20 2002 49 51
26. J. Harborth, S.M. Elbashir, K. Bechert, T. Tuschl, and K. Weber Identification of essential genes in cultured mammalian cells using small interfering RNAs J. Cell Sci. 114 2001 4557 4565
27. H.J. Cho, H.G. Jeong, J.S. Lee, E.R. Woo, J.W. Hyun, M.H. Chung, and H.J. You Oncogenic H-Ras enhances DNA repair through the Ras/phosphatidylinositol 3-kinase/Rac1 pathway in NIH3T3 cells, Evidence for association with reactive oxygen species J. Biol. Chem. 277 2002 19358 19366
28. M. Kartalou, and J.M. Essigmann Mechanisms of resistance to cisplatin Mutat. Res. 478 2001 23 43
29. W. Schmidt, and S.G. Chaney Role of carrier ligand in platinum resistance of human carcinoma cell lines Cancer Res. 53 1993 799 805
30. A. Eastman, and N. Schulte Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II) Biochemistry 27 1988 4730 4734
31. L.N. Petersen, E.L. Mamenta, T. Stevnsner, S.G. Chaney, and V.A. Bohr Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity Carcinogenesis 17 1996 2597 2602
32. N. Sheibani, M.M. Jennerwein, and A. Eastman DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA Biochemistry 28 1989 3120 3124
33. R.L. Rolig, S.K. Layher, B. Santi, G.M. Adair, F. Gu, A.J. Rainbow, and R.S. Nairn Survival, mutagenesis, and host cell reactivation in a Chinese hamster ovary cell ERCC1 knock-out mutant Mutagenesis 12 1997 277 283
34. K.V. Ferry, T.C. Hamilton, and S.W. Johnson Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF Biochem. Pharmacol. 60 2000 1305 1313
35. R. Metzger, C.G. Leichman, K.D. Danenberg, P.V. Danenberg, H.J. Lenz, K. Hayashi, S. Groshen, D. Salonga, H. Cohen, L. Laine, P. Crookes, H. Silberman, J. Baranda, B. Konda, and L. Leichman ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy J. Clin. Oncol. 16 1998 309 316
36. Y. Shirota, J. Stoehlmacher, J. Brabender, Y. Xiong, H. Uetake, K.D. Danenberg, S. Groshen, D.D. Tsao-Wei, P.V. Danenberg, and H. Lenz ERCCI and thymidylate synthase MRNA levels predict survival for coloreml cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy J. Clin. Oncol. 19 2001 4298 4304
37. R.V. Lord, J. Brabender, D. Gandara, V. Alberola, C. Camps, M. Domine, F. Cardenal, J.M. Sanchez, P.H. Gumerlock, M. Taron, J.J. Sanchez, K.D. Danenberg, P.V. Danenberg, and R. Rosell Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer Clin. Cancer Res. 8 2002 2286 2291
38. B. Desoize, and C. Madoulet Particular aspects of platinum compounds used at present in cancer treatment Crit. Rev. Oncol. Hematol. 42 2002 317 325